Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHIRST-2: Long-Term Tadalafil in PAH
NCT00549302Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2005
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of tadalafil in pulmonary arterial hypertension (PAH), sponsored by Eli Lilly and Company. Started Dec 2005; status: completed.
02
Drugs
tadalafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00549302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549302.